Cover Image, Volume 15, Issue 3
Cytological grading of canine cutaneous mast cell tumours : is haematoxylin and eosin staining better than May‐Grünwald–Giemsa?
Proteases as prognostic markers in human and canine cancers
Quality of life assessment in dogs and cats receiving chemotherapy – a review of current methods
Gastric carcinoma in canines and humans, a review
Potency and stability of compounded cyclophosphamide : a pilot study
Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats
The effects of sulforaphane on canine osteosarcoma proliferation and invasion
Photodynamic detection of canine mammary gland tumours after oral administration of 5‐aminolevulinic acid
Use of indirect lymphography to identify sentinel lymph node in dogs : a pilot study in 30 tumours
Establishment and characterization of a canine soft tissue sarcoma patient‐derived xenograft model
Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells
The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision
Identification of occult micrometastases and isolated tumour cells within regional lymph nodes of previously diagnosed non‐metastatic (stage 0) canine carcinomas
Cell cycle kinetics, apoptosis rates and gene expressions of MDR‐1, TP53, BCL‐2 and BAX in transmissible venereal tumour cells and their association with therapy response
Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer†
Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour
Association of breed and histopathological grade in canine mast cell tumours
Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy : 77 cases (1999–2013)
Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of canine follicular lymphoma
The use, publication and future directions of immunocytochemistry in veterinary medicine : a consensus of the Oncology‐Pathology Working Group
Patterns of lymph node metastasis identified following bilateral mandibular and medial retropharyngeal lymphadenectomy in 31 dogs with malignancies of the head
Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro
DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs : a phase I dose‐finding study
Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan‐1) for nuclear medicine preclinical trials on spontaneous tumours
Immortalization and characterization of a new canine mammary tumour cell line FR37‐CMT
Evaluation of immunomodulatory effect of recombinant human granulocyte‐macrophage colony‐stimulating factor on polymorphonuclear cell from dogs with cancer in vitro
Canine cell line, IPC‐366, as a good model for the study of inflammatory breast cancer
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4‐antigen electrovaccination
Evaluation of the global DNA methylation in canine mast cell tumour samples by immunostaining of 5‐methyl cytosine
A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006–2013)†
Conformity and controversies in the diagnosis, staging and follow‐up evaluation of canine nodal lymphoma : a systematic review of the last 15 years of published literature†
Expression of VEGFR and PDGFR‐α/‐β in 187 canine nasal carcinomas
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours
Defect in ND2, COX2, ATP6 and COX3 mitochondrial genes as a risk factor for canine mammary tumour
Outcome in dogs with advanced (stage 3b) anal sac gland carcinoma treated with surgery or hypofractionated radiation therapy
Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild‐type p53
Canine acute leukaemia : 50 cases (1989–2014)¶
Non‐immunosuppressive FTY720‐derivative OSU‐2S mediates reactive oxygen species‐mediated cytotoxicity in canine B‐cell lymphoma